Oath Surgical is a technology company.
Oath Surgical has raised $24.0M across 1 funding round.
Oath Surgical has raised $24.0M in total across 1 funding round.
Oath Surgical has raised $24.0M in total across 1 funding round.
Oath Surgical's investors include FPV Fund, Kinnevik, Playground Global.
Oath Surgical is a health tech startup building a vertically integrated platform for outpatient surgery, centered on OathOS, a proprietary AI-powered operating system that manages the full surgical journey from referral to recovery.[1][2][3] It operates tech-first ambulatory surgery centers (ASCs) co-owned by vetted surgeons, targeting complex procedures traditionally done in hospitals, to deliver value-based care with better outcomes, lower costs, and reduced administrative burden for patients, surgeons, and payors.[1][2][4] Launched in Portland, Oregon, with national expansion plans, the company serves patients needing higher-acuity outpatient surgeries, surgeons seeking ownership and efficiency tools, and payors aligned on cost savings; it has raised $35M total, including a $24M oversubscribed Series A in October 2025, signaling strong growth momentum amid rising demand for outpatient care.[3][6]
Oath Surgical emerged from stealth in May 2025, founded by Dr. Oliver Keown, a trained physician, former head of Intuitive Ventures (the venture arm of surgical robotics firm Intuitive Surgical), and veteran of medtech investing.[1][2][3] Keown's idea stemmed from a decade observing surgical inefficiencies—fragmented systems, hospital dependency for complex procedures, and misaligned incentives—despite advances in minimally invasive tech and robotics enabling safer outpatient care.[3][4] Pivotal early traction included launching its first ASC in Portland with OathOS already in use for AI scribes, automated charting, and pre-op workflows, plus securing initial funding from Oxford Science Enterprises and others before the Series A led by FPV Ventures.[1][2][6]
Oath Surgical stands out through vertical integration of AI software and owned ASCs, creating a full-stack system rather than point solutions:
Oath Surgical rides the shift toward outpatient and value-based surgical care, fueled by robotics/minimally invasive tech enabling complex procedures outside hospitals, amid market forces like rising healthcare costs, payor pressure for efficiency, and AI's maturation for backend automation.[1][3][4] Timing is ideal post-2025 funding boom, with $35M enabling oncology expansion and national density in regional networks, countering legacy systems' bloat.[3][6] It influences the ecosystem by proving scalable AI-physical integration, inspiring surgeon-centric models, and unlocking ROI through episode-of-care ownership, potentially accelerating ASC growth from 5-10% of U.S. surgeries to higher shares.[2][4]
Oath Surgical is poised to scale its national network of AI-powered ASCs, expanding into oncology and more specialties with fresh Series A capital, while refining OathOS for deeper payor integrations and performance analytics.[6][8] Trends like AI ubiquity in healthcare, ASC proliferation (projected to handle 50%+ of procedures), and value-based shifts will propel it, though execution risks include regulatory hurdles and surgeon recruitment. Its influence may evolve from pioneer to platform leader, redefining surgery as efficient, outpatient-first—echoing its launch thesis that tech can untether complex care from hospitals for good.[1][3]
Oath Surgical has raised $24.0M across 1 funding round. Most recently, it raised $24.0M Series A in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2025 | $24.0M Series A | FPV Fund, Kinnevik, Playground Global |